fbpx

Welpar Pharmbizz IPO – Listing, Allotment, Subscription, GMP & DRHP

Welpar Pharmbizz Limited, is engaged in the business of distributing pharmaceutical products of various healthcare companies such as Lupin, Intas Pharmaceuticals, Abbott Healthcare, Glaxo Smithkline Pharma, Torrent Pharmaceuticals, Macleods Pharmaceutical and many more. 

Let’s have a detailed review of the company and analytics of the Welpar Pharmbizz IPO release date, IPO offer price, subscription, Welpar Pharmbizz IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.


Welpar Pharmbizz IPO Review & Ratings

IPO Ratings & Review
CriteriaRatings
Industry Sentiments8.5/10
Industry Ranking7.8/10
Company Background7.9/10
Company Reputation7.9/10
Competitive Edge7.7/10
Financial Statements7.8/10
Popularity Index8.4/10
Promoters Reputation7.7/10
Retail Appetite7.9/10
Top Brokers Review7.9/10
Overall Ratings8.1/10
Star Ratings★★★★☆

Summary of Welpar Pharmbizz IPO

Welpar Pharmbizz IPOWelpar Pharmbizz Limited, is engaged in the business of distributing pharmaceutical products of various healthcare companies such as Lupin, Intas Pharmaceuticals, Abbott Healthcare, Glaxo Smithkline Pharma, Torrent Pharmaceuticals, Macleods Pharmaceutical and many more.The company’s key area of focus and business is around distribution of branded ethical medicines. Welpar Pharmbizz Limited works with more than 150 national and multi-national pharmaceutical companies, for distribution a product portfolio of more than 10,000 SKUs. Initial public offering of up to 50,50,000* Equity Shares of Rs. 10.00 each fully paid-up of the Company for cash at a price of Rs. [●] per Equity Share aggregating to Rs. [●] Lakh.

From FY 2015-16 to FY 2017-2018, as per the Restated Financial Statements,

  • For the Period ended July 31, 2018 the total revenue of the Company as per the restated consolidated financials was Rs. 1,809.71 Lakh and Rs. 7,421.58 Lakh for the year ended March 31, 2018. Further, the PAT as per the restated consolidated financials for the period ended July 31, 2018 was Rs. 121.18 Lakh and fiscal year ended on March 31, 2018 was Rs. 390.29 Lakh.
  • The net asset value per Equity Share was Rs. 1,312.30 and Rs. 1,264.70 as of May 30, 2018 and March 31, 2018, respectively, as per the Restated Standalone Financial Statements.
  • Their profit after tax for the period May 10, 2018 to July 31, 2018 was Rs. 121.18 Lakh while that for the period April 01, 2018 to May 09, 2018 was Rs. 51.86 Lakh forming 6.70% and 6.83% of the total revenue respectively. profit after tax increased by 995.23% to Rs. 390.29 Lakh for the financial year 2017-18 from Rs. 35.64 Lakh for the financial year 2016-17 due to aforementioned reasons. profit after tax increased by 27.89% to Rs. 35.64 Lakh for the financial year 2016-17 from Rs. 27.86 Lakh for the financial year 2015-16.

The Promoters of this company are Mr. Paras Kanhaiyalal Chhajed, Mr. Dipesh Paras Chhajed, Mr. Manish Paras Chhajed. The lead manager to the issue is  Gretex Corporate Services Private Limited and the Registrar to this issue is Link Intime India Private Limited.



Welpar Pharmbizz IPO Date

The opening and the closing date of Welpar Pharmbizz IPO is not known yet.


Welpar Pharmbizz IPO Subscription

Day / DateQIBNIIRIITotal Subscription
Day 1 
Day 2
Day 3
Day 4
Day 5
Shares Offered or Net Issue

The shares subscribed by the public will be updated herein on a daily basis, once the IPO is open for subscription.


Welpar Pharmbizz IPO Allotment Status

Here, you can find the Allotment Status of this IPO.


Welpar Pharmbizz IPO Price Band

The face value of each share is Rs 10, but the price band of the IPO is not yet disclosed. 


Welpar Pharmbizz IPO Equity Share Offering

Initial public offering of up to [●] Equity Shares for cash at price of Rs. [●] per Equity Share (including a premium of Rs. [●] per Equity Share).


Welpar Pharmbizz Limited – Company Overview

Welpar Pharmbizz Limited (formerly known as Welcome Agencies) is the Public limited Company and Welcome Enterprises is a partnership Firm. Welcome Enterprises was incorporated as partnership Firm on August 09, 1982. Welpar Pharmbizz Limited holds the majority stake as partner in Welcome Enterprises.

Welpar Pharmbizz Limited, is engaged in the business of distributing pharmaceutical products of various healthcare companies such as Lupin, Intas Pharmaceuticals, Abbott Healthcare, Glaxo Smithkline Pharma, Torrent Pharmaceuticals, Macleods Pharmaceutical and many more. They operate as a C & F Agent, stockiest and distributor in Mumbai, Maharashtra based out of the office in Wadala, Mumbai and dispatch centre also in Mumbai.

Their product portfolio includes: a) Ethical Medicines b) Ayurveda Medicines c) Surgical Implants d) and Health Monitoring Systems from a large variety of suppliers which are leading pharmaceutical companies in the business.

Competitive Strengths of Welpar Pharmbizz Limited:

  • Management and Employee expertise;
  • Quality Service;
  • Needs of customers;
  • High level of customer satisfaction;
  • Existing distribution and sales networks;
  • Distribution network

Business strategies of Welpar Pharmbizz Limited:

  • Using Established Relationships with Pharmaceutical Companies
  • New Product Segments
  • Enhancing & Retaining the Customer Base
  • Improving Operational & Functional Efficiencies
  • Building-up as a Professional Organisation
  • Develop cordial relationship with the Suppliers, Customer and employees
  • Believe in traditional marketing, which is the process of direct customer contact to create exchanges that satisfy the Company’s objectives.

Welpar Pharmbizz Limited – Financial Statements

A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

Financial Summary: 

Amount (in INR & lakhs) 
30-Jul-1809-May-1831-Mar-1831-Mar-1731-Mar-16
Total Assets5,061.254,389.674,039.942,139.212,063.55
Total Revenue1,809.71759.567,421.587,670.117,443.83
Total Expense1,631.86684.636,825.707,615.967,402.73
Profit After Tax121.1851.86390.2935.6427.64

Earnings per Equity Share (in lakhs)

31-Jul-1831-May-1831-Mar-1831-Mar-1731-Mar-16
Basic & Diluted8.5748.92368.2033.6326.29

From the above statements, one could find that the Welpar Pharmbizz Limited may perform well.


Welpar Pharmbizz IPO – Promoters

The Promoters of this company are:

  • Mr. Paras Kanhaiyalal Chhajed
  • Mr. Dipesh Paras Chhajed
  • Mr. Manish Paras Chhajed

List of Related Parties (Key Managerial Personnel)

  • Mr. Dipesh Paras Chhajed – Promoter and Managing Director
  • Mr. Kiran Paras Chhajed –Whole Time Director
  • Mr. Manish Paras Chhajed – Promoter, Executive Director and Chief Financial Officer
  • Ms. Mitti Mitesh Jain – Company Secretary and Compliance Officer

Interest in promotion of the Company

Company is currently promoted by the Promoters in order to carry on its present business. Promoters are interested in the Company to the extent of their shareholding and directorship of the Individual Promoter in the Company and the dividend declared, if any, by the Company. The Promoters are interested in the transactions entered into the Company and the Promoter Group.

Property Interest

The promoters along with the promoter group will continue to hold collectively some percentage of the equity share capital of the company. As a result of the same, they will be able to exercise significant influence over the control of the outcome of the matter that requires approval of the majority shareholders vote.

Interest in Intellectual Rights of the Company

Promoters has not shown any interest in acquiring the intellectual rights of the company.


Welpar Pharmbizz IPO Offer Details or Issue Details

Particulars No. Of Equity Shares
 Equity Shares Offered Up to 50,50,000* Equity Shares of Rs. 10.00 each fully
paid-up of the Company for cash at a price of Rs. [●] per Equity Share aggregating to Rs. [●] Lakh
 Of which:
 Reserved for Market Makers [●] Equity Shares of Rs. 10.00 each fully paid-up of the
Company for cash at a price of Rs. [●] per Equity Share
aggregating to Rs. [●] Lakh
 Net Issue to the Public [●] Equity Shares of Rs. 10.00 each fully paid-up of the
Company for cash at a price of Rs. [●] per Equity Share
aggregating to Rs. [●] Lakh
QIB Portion[●] Equity Shares of Rs. 10.00 each fully paid-up of the
Company are available for allocation
Of which
Available for allocation to Mutual Funds only (5% of the QIB portion) (Excluding the Anchor Investor Portion)[●] Equity Shares of Face Value of Rs. 10/- each 
Balance for all QIBs including Mutual Funds[●] Equity Shares of Face Value of Rs. 10/- each 
 Retail Investors Portion [●] Equity Shares of Rs. 10.00 each fully paid-up of the
Company for cash at a price of Rs. [●] per Equity Share
aggregating to Rs. [●] Lakh will be available for allocation to Investors upto Rs. 2.00 Lakh
 Non-Retail Investors Portion[●] Equity Shares of Rs. 10.00 each fully paid-up of the
Company for cash at a price of Rs. [●] per Equity Share
aggregating to Rs. [●] Lakh will be available for allocation to Investors above Rs. 2.00 Lakh
 Equity Shares outstanding prior to the Issue1,33,97,000 Equity Shares
 Equity Shares outstanding after the IssueUpto [●] Equity Shares of face value of Rs. 10 each

Welpar Pharmbizz IPO Issue Object

These are the IPO Issue Objects of the company

  • Funding the Working Capital requirements of the Company:
  •  Repayment/ pre-payment of certain unsecured loans availed from banks and financial institutions by the company; and
  •  General Corporate Purposes

List of Upcoming IPOs in 2018

Pommys Garments IPOIndo US Biotech IPOMedibios Laboratories IPOHariom Pipe IPO
R R Industrial IPOSorich Foils IPO20 Microns IPOShree Vasu Logistics IPO

Welpar Pharmbizz IPO – Basis of the Offer Price

The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

Qualitative factors are:

  • Management and Employee expertise;
  • Quality Service;
  • Needs of customers;
  • High level of customer satisfaction;
  • Existing distribution and sales networks;
  • Distribution network

The relevant quantitative factors are:

On the basis of standalone statement:-

Basic & Diluted EPSRONW in %NAV (Rs.)
31-Mar-1626.295.98
31-Mar-1733.637.25
31-Mar-18368.2029.11
1264.70
  • Competitive Peers:

They believe that there are no listed Companies in India which are engaged in the business of distributing pharmaceutical products of various healthcare companies.


List of Latest IPOs of 2018

Fine Organic IPOIndoStar Capital IPOCapricorn Food Products IPOFlemingo Travel Retail IPO
Nazara Technologies IPOGenius Consultants IPORail Vikas Nigam IPOVarroc Engineering IPO

Welpar Pharmbizz IPO Lead Managers

Lead Managers
GRETEX CORPORATE SERVICES PRIVATE LIMITED
Registered Office: Office no.102, 1st Floor, Kanakia Atrium-2, Chakala Andheri Kurla
Road, Behind Courtyard Marriot, Mumbai – 400 093
Tel No.: +91 – 22 – 6708 6181
Email:
Website: www.gretexcorporate.com
Contact Person: Ms. Amina Khan
SEBI Registration No: INM000012177
CIN: U74999MH2008PTC288128

Welpar Pharmbizz IPO Registrar to offer

Registrar to the Offer
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247, Park, L.B.S. Marg, Vikhroli (West), Mumbai – 400 083
Tel No.: +91 – 22 – 4918 6200
Fax No.: +91 – 22 – 4918 6195
Email:
Website: www.linkintime.co.in
Contact Person: Ms. Shanti Gopalkrishnan
SEBI Registration No: INR000004058
CIN: U67190MH1999PTC118368

Other Details:

  • Statutory Auditor – M/s Pankaj P. Sanghavi & Co., Chartered Accountants
  • Peer Review Auditor – M/s Pankaj P. Sanghavi & Co., Chartered Accountants
  • Bankers to the Company – NKGSB Co-op Bank Limited, Wadala

Welpar Pharmbizz IPO Review by Top 10 Stock Brokers

Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromoters Reputation
Angel Broking7.5/107.4/108.5/108.1/107.1/10
Sharekhan7.2/107.1/108.6/108.1/107.2/10
Kotak Securities7.3/107.5/108.4/108.1/107.3/10
ICICI Direct7.3/107.3/108.7/108.1/107.1/10
IIFL7.5/107.2/108.8/108.0/107.1/10
Edelweiss7.5/107.4/108.4/108.3/107.2/10
Zerodha7.4/107.1/108.5/108.1/107.0/10
5Paisa7.1/107.1/108.4/108.1/107.1/10
Karvy7.4/107.3/108.2/108.1/107.1/10
Motilal Oswal7.1/107.1/108.6/108.3/107.2/10

Welpar Pharmbizz IPO Grey Market Premium

The Welpar Pharmbizz IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 


Subscribe to Welpar Pharmbizz IPO

Fill the Details Below
  1. Subscribe to IPOOpen Demat AccountBecome Sub Broker

Welpar Pharmbizz IPO News

News 1 – IPO ISSUE OPENS SOON (Download Prospectus)


Market Guide

What is IPO?
IPO Investment
IPO Valuation
Upcoming IPOs

Featured Topics

Featured Topics
Best Discount Broker in India
Best Full Service Broker in India
Best Stock Broker in India
Best Intraday Trading Brokers in India
Best Demat Account
Brokerage Calculator
Top 10 Sub Broker Partner in India
Sub Broker Franchise
Broking Franchisee

Leave a Reply

Your email address will not be published. Required fields are marked *

Get 100% IPO Allotment Guarantee! Subscribe to IPO
×

Share your details & Become Sub Broker Now!

  1. Become Sub BrokerOpen Demat Account

Offer valid for limited time.

×

Share your details & Open Demat A/C Now!

  1. Open Demat AccountBecome Sub Broker

Offer valid for limited time.

×

Share your details & Get IPO Allotment Now!

  1. Invest in IPOOpen Demat Account

Offer valid for limited time.

×

Share your details & Invest in PMS Now!

  1. Invest in PMSOpen Demat Account

Offer valid for limited time.